Chrisandra L. Shufelt, MD

Director, Women's Hormone and Menopause Program

Associate Director, Barbra Streisand Women's Heart Center

Associate Director, Preventative and Rehabilitative Cardiac Center

Associate Professor, Medicine

Chrisandra L. Shufelt, MD

East Medical Office Tower
8631 W 3rd St
Ste 740
Los AngelesCA
90048

Phone:

310-423-9660

Fax:

310-423-9668

Chrisandra L. Shufelt, MD

Director, Women's Hormone and Menopause Program

Associate Director, Barbra Streisand Women's Heart Center

Associate Director, Preventative and Rehabilitative Cardiac Center

Associate Professor, Medicine

  • General Internal Medicine

Contraception (Birth Control)

Heart Disease

Hormone Replacement Therapy (HRT)

Menopause

Chrisandra Shufelt, MD, MS, FACP, NCMP is the associate director of the Barbra Streisand Women's Heart Center and the Preventive and Rehabilitative Cardiac Center at the Smidt Heart Institute. She also directors the Women's Hormone and Menopause Program and is an expert in women’s hormones and heart disease. Dr. Shufelt provides personalized menopause treatment (hormone and non-hormone options), high-risk hormone counseling for women with or at risk for heart disease and cardiac risk assessments. She has several leadership roles in the American College of Physicians and the North American Menopause Society (NAMS) and is a NAMS certified menopause practitioner. Dr. Shufelt is currently a member of the NAMS Board of Trustees and the editorial board for the journal Menopause. She is also a member of the Endocrine Society and the American Heart Association. Dr. Shufelt is the research director of the non-invasive vascular research core laboratory within the Barbra Streisand Women's Heart Center. Her research is NIH/NHLBI-funded and focuses on premenopausal women with amenorrhea due to low estrogen and the impact of hormones on the immune system, vascular health and heart disease. She is also a co-investigator on many studies at Cedars-Sinai, including those focusing on heart disease affecting small arteries in women. She has published in numerous peer-reviewed journals such as the Journal of the American College of Cardiology, the Journal of the American Medical Association and Menopause Journal and has presented at both national and international conferences.

  • Medical School: University of Southern California School of Medicine, 2004
  • Residency: Santa Barbara Cottage Hospital, 2007
  • Fellowship: Cedars-Sinai, 2008
  • NAMS Board of Trustees, 2018-present
  • NAMS/Thomas Clarkson Outstanding Clinical and Basic Science Research Award, 2018
  • European Menopause and Andropause Society, Advisory Board Member, 2017-present
  • Menopause Journal, Editorial Board Member, 2017-present
  • Clinical Scholars Program, Senior Clinical Scholar, 2010-12

Click here for a list of peer-reviewed publications.

  • Shufelt CL, Merz CN, Prentice RL, Pettinger MB, Rossouw JE, Aroda VR, Kaunitz AM, Lakshminarayan K, Martin LW, Phillips LS, et al. Hormone therapy dose, formulation, route of delivery, and risk of cardiovascular events in women: findings from the Women's Health Initiative Observational Study. Menopause. 2014 Mar;21(3):260-266.
  • Shufelt CL, Torbati T, Dutra E. Hypothalamic Amenorrhea and the Long-Term Health Consequences. Semin Reprod Med. 2017 May;35(3):256-262. Epub 2017 Jun 28.
  • Shufelt C, Elboudwarej O, Johnson BD, Mehta P, Bittner V, Braunstein G, Berga S, Stanczyk F, Dwyer K, Merz CN. Carotid artery distensibility and hormone therapy and menopause: the Los Angeles Atherosclerosis Study. Menopause. 2016 Feb;23(2):150-157.

English

Make an Appointment

Call

1-800-CEDARS-1

(1-800-233-2771)

Available 24 Hours A Day

or

Many of the physicians who have medical staff privileges to practice medicine at Cedars-Sinai Medical Center are independent physicians, and not employees or agents of the hospital. These independent physicians bill separately for their services. You should contact your physician to determine their status and billing practices.